Sakurai K, Matsubayashi T, Aritomi H, Iwanami S, Marumo F, Kusano S
Department of Radiology and Orthopedic Surgery, Kitasato University School of Medicine.
Nihon Igaku Hoshasen Gakkai Zasshi. 1991 Dec 25;51(12):1467-74.
The CT numbers of cortex at the level of 20 cm (CT20) and spongiosa in the lateral condyle at the level of 2 cm (CT20) proximal from the distal end of the femur, and the bone mineral density of spongiosa in the L3 body (BMD), were obtained by QCT. The study included 43 female patients with rheumatoid arthritis (RA), 71 female patients with primary osteoporosis (OP), 20 female nondialyzed patients with chronic renal failure (CRF:nonHD), 37 hemodialyzed patients (CRF:HD), including 13 parathyroidectomized patients (CRF:HD, PTX), and 10 healthy volunteers. CT20 correlated closely with age in RA. CT02 and BMD correlated closely with age in RA and OP. CT20 and CT02 correlated closely with the duration of hemodialysis in CRF:HD, but not with the duration of disease in RA. The values of CT20 and CT02 in the CRF:HD. PTX group were significantly lower than those in the other CRF groups. BMD in the RA groups was not different from that of healthy volunteers. The CT20 values of the one-third of RA patients older than 60 years were extremely low compared with those of the other two-thirds. The results indicated that BMD was useful in assessing bone mineral content in OP, but not in RA. CT02 and CT20 were useful in assessing bone mineral content in these three diseases, CT20 was especially useful for patients in the CRF:HD group and those with RA older than 60 years, but it was not useful in the CRF:nonHD group.
通过定量CT(QCT)测量股骨远端近端2 cm处外侧髁的松质骨在20 cm水平的皮质骨CT值(CT20)以及L3椎体松质骨的骨密度(BMD)。该研究纳入了43例类风湿关节炎(RA)女性患者、71例原发性骨质疏松症(OP)女性患者、20例未接受透析的慢性肾衰竭(CRF:nonHD)女性患者、37例接受血液透析的患者(CRF:HD),其中包括13例接受甲状旁腺切除术的患者(CRF:HD,PTX)以及10名健康志愿者。在RA患者中,CT20与年龄密切相关。在RA和OP患者中,CT02和BMD与年龄密切相关。在CRF:HD患者中,CT20和CT02与血液透析时间密切相关,但与RA患者的病程无关。CRF:HD、PTX组的CT20和CT02值显著低于其他CRF组。RA组的BMD与健康志愿者无差异。60岁以上的RA患者中有三分之一的CT20值与另外三分之二相比极低。结果表明,BMD有助于评估OP患者的骨矿物质含量,但对RA患者无效。CT02和CT20有助于评估这三种疾病的骨矿物质含量,CT20对CRF:HD组患者以及60岁以上的RA患者尤为有用,但对CRF:nonHD组患者无效。